Detection of antithrombin III microheterogeneity.

Area of Science:

• Biochemistry
• Clinical Chemistry
• Immunology

Background:

• Antithrombin III (ATIII) is a crucial anticoagulant protein.
• Microheterogeneity refers to variations in protein structure.
• ATIII levels and structure can be affected by various clinical states.

Purpose of the Study:

• To investigate antithrombin III microheterogeneity using isoelectric focusing and immunofixation.
• To compare ATIII patterns in healthy individuals versus patients with specific clinical conditions.
• To determine if ATIII microheterogeneity changes are associated with clinical abnormalities.

Main Methods:

• Isoelectric focusing (IEF) was employed to separate ATIII isoforms.
• Immunofixation was used to identify and confirm ATIII bands.
• Plasma samples from healthy controls and patients (liver disease, nephrotic syndrome, post-surgery, anticoagulant therapy) were analyzed.

Main Results:

• Normal plasma exhibited ATIII microheterogeneity with 10 bands (pI 5.0-5.7).
• A unique ATIII variant, unrelated to clinical disorders, was identified.
• Reduced ATIII concentrations and band intensity were observed in liver disease, nephrotic syndrome, and anticoagulant therapy groups.
• Significant alterations in ATIII microheterogeneity were noted post-surgery and in nephrotic syndrome patients.

Conclusions:

• Antithrombin III exhibits significant microheterogeneity in healthy individuals.
• Specific clinical conditions, including post-surgery and nephrotic syndrome, are associated with altered ATIII microheterogeneity.
• Changes in ATIII subpopulations may be clinically relevant and indicative of underlying disease processes.